Concord Drugs — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Concord Drugs holds 45.08% of the company. At a market capitalisation of ₹105 cr, that holding is worth ₹47 cr.

Promoter stake

45.08%

Value of holding

₹47 cr

Market cap

₹105 cr

Stake change

—

Promoter holdings in Pharmaceuticals & Biotechnology

Sun Pharmaceutical Industries Ltd54.48%₹2.41 lakh cr
Divis Laboratories Ltd51.88%₹1.28 lakh cr
Torrent Pharmaceuticals Ltd60.78%₹1.15 lakh cr
Zydus Lifesciences Ltd75.02%₹83.75k cr
Mankind Pharma Ltd72.63%₹68.40k cr
Aurobindo Pharma Ltd51.88%₹50.14k cr

What this figure is, and is not

The value shown is Concord Drugs's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.